Carregant...
Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker
In randomized clinical trials, the primary outcome, Y, often requires long-term follow-up and/or is costly to measure. For such settings, it is desirable to use a surrogate marker, S, to infer the treatment effect on Y, Δ. Identifying such an S and quantifying the proportion of treatment effect on Y...
Guardat en:
| Publicat a: | Biometrika |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7315285/ https://ncbi.nlm.nih.gov/pubmed/32587413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/biomet/asz065 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|